| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash used in operating activities | -9,030,196 | -6,114,098 |
| Net cash provided by investing activities | 0 | 0 |
| Costs paid in connection with private placements | 45,166 | - |
| Net cash (used in) provided by financing activities | -45,166 | 0 |
| Net decrease in cash, cash equivalents and restricted cash | -9,075,362 | -6,114,098 |
| Cash and cash equivalents at beginning of period | 21,462,008 | - |
| Cash and cash equivalents at end of period | 12,386,646 | - |
Minerva Neurosciences, Inc. (NERV)
Minerva Neurosciences, Inc. (NERV)